INS and type 1 diabetes mellitus: Blood‐glucose monitoring and glucose‐tolerance tests in T1D mice showed that the ROSSENSE system provided sufficient insulin production to maintain daily glycemia and attenuate postprandial glycemic excursions for all the ROS‐enhancing compounds under study.